Pictured: Dr. Khashayar Farrokzhad, ZiP Diagnostics Senior Research Officer, in front of ZiP's booth.
ZiP Diagnostics is excited to attend POC23, the 1st Australasian conference on point-of-care testing for infectious diseases, held at Sheraton Grand Sydney Hyde Park. This is a two-day conference (14-15 March) that brings together leaders in point-of-care testing (including research and industry), clinicians and other stakeholders with the goal of identifying challenges and solutions to decentralise and scale-up accurate diagnostic testing in community settings. ​ ZiP will exhibit their ZiP-CoVx-P2 point-of-care test*. The test is performed on a portable test system and provides results for SARS-CoV-2 within 30 minutes. Using this state-of-the-art technology, ZiP is developing a test menu that extends to other respiratory viruses, blood-borne viruses, sexually transmitted diseases, and mosquito-borne diseases. ​ Come see us at booth number 2, POC23, Sheraton Grand Sydney Hyde Park! *The ZiP-CoVx-P2 test is not approved for use in all markets.
Comentarios